The DNA Repair Company has appointed Brian Ward as executive vice president and named Stella Quan senior director of product development.
Ward formerly was senior VP for Genomic Health. He also has served as president of medical genetic services and senior vice president of operations at Myriad Genetic Laboratories, and he has worked at Genzyme Genetics and at the University of Colorado.
Quan was director of immunoassay development for bioMérieux, was senior director of operations at Tripath Oncology, and was involved in research and development at Chiron.
Stefan Müllner has been named the new CEO of Protagen, succeeding Christoph Hüls, who is leaving the firm to join an unnamed pharmaceutical company. Müllner has been the firm's chief scientific officer.